Policy-focused browsing for Hawaii legislation.
| Bill | Title | Status | Sponsor |
|---|---|---|---|
| SB 2420 |
Constitutional Amendment; Cannabis; Legalization; Adult Use 2026 | Senate
|
in_committee | Joy A. San Buenaventura |
| HB 1624 |
Constitutional Amendment; Cannabis; Legalization; Adult Use 2026 | House
|
in_committee | David A. Tarnas |
| HB 1625 |
DCCA; DOH; DOA; DoTax; Hawaii Cannabis and Hemp Office; Adult-Use Cannabis; Medical Cannabis; Hemp; Appropriations 2026 | House
|
in_committee | David A. Tarnas |
| HB 1767 |
Health Insurance; Health Insurers; Mutual Benefit Societies; Health Maintenance Organizations; Prescription Drug Coverage; Opioid Antagonists 2026 | House
|
in_committee | Jeanne Kapela |
| HB 1856 |
DLE; Medical Cannabis; Medical Records; Inspection; Repeal 2026 | House
|
in_committee | Gregg Takayama |
| SB 1064 SD2 |
DOH; Medical Cannabis; Cannabis Cultivator; Licensure; Requirement; Cease and Desist Notice; Penalty; Violations; Affirmative Defense; Conclusive Basis; Medical Cannabis Registry and Regulation Special Fund; Exceptions; Appropriations 2026 | Senate
|
failed | Aquino |
| SB 319 |
Marijuana; Possession; Decriminalization 2026 | Senate
|
failed | Joy A. San Buenaventura |
| SB 1613 SD1 |
DCCA; DOH; DOA; DoTax; Hawaii Cannabis and Hemp Office; Adult-Use Cannabis; Medical Cannabis; Hemp; Appropriation 2026 | Senate
|
in_committee | Joy A. San Buenaventura |
| SB 1633 SD1 |
DOH; Green Building Tax Credit; Edible Cannabinoid Products; Tetrahydrocannabinol Concentration Limit; Hemp Biomass; Hemp Program; High THC Products 2026 | Senate
|
in_committee | Mike Gabbard |
| HB 1109 HD1 |
Department of Health; Manufactured Hemp Products; Minimum Age; Prohibition 2026 | House
|
in_committee | Nadine K. Nakamura |
| SB 851 |
DOH; EMTs; EMT-Paramedics; Buprenorphine; Opioid Antagonist; Training; Rules 2026 | Senate
|
failed | Dru Mamo Kanuha |
| HB 1246 HD1 |
DCCA; DOH; DOA; DoTax; Hawaii Cannabis and Hemp Office; Adult-Use Cannabis; Medical Cannabis; Hemp; Appropriations 2026 | House
|
in_committee | David A. Tarnas |
| SB 661 SD1 |
DOA; Programs; Plant-Based Building Materials; Biocements; Hemp; Bamboo; Appropriations 2026 | Senate
|
in_committee | Mike Gabbard |
| HB 325 HD1 |
Medical Cannabis; Qualifying Patients; Discrimination; Employer; Employee; Potentially Dangerous Occupations; Exemptions 2026 | House
|
in_committee | Jeanne Kapela |
| HB 600 |
DOH; Medical Cannabis; Out-of-State Patients; Registration; Telehealth; Fees 2026 | House
|
failed | Diamond Garcia |
| HB 1204 |
Medical Cannabis; Primary Caregivers 2026 | House
|
in_committee | Sean Quinlan |
| HB 1390 |
DOH; Cannabis; Medical Use; Cultivation; Patients; Caregivers 2026 | House
|
in_committee | Sean Quinlan |
| HB 1399 |
DOE; Opioid Antagonist; Classrooms; Appropriation 2026 | House
|
in_committee | Diamond Garcia |
| HB 1416 |
DOH; ADAD; Informational Campaign; Prevention Services; Report; Appropriations 2026 | House
|
in_committee | Gregg Takayama |
| SB 1427 |
Manufactured Hemp Products; Definition; DOH 2026 | Senate
|
in_committee | Ronald D. Kouchi |
| SB 1428 |
Department of Health; Manufactured Hemp Products; Minimum Age; Prohibition 2026 | Senate
|
in_committee | Ronald D. Kouchi |
| SB 1430 |
DOH; Manufactured Hemp Products; Registration; Definitions 2026 | Senate
|
in_committee | Ronald D. Kouchi |
| SB 1519 |
Insurance Commissioner; Ensuring Transparency in Prior Authorization Act; Prior Authorization; Utilization Review Entity; Adverse Determination; Health Care Services; Reports 2026 | Senate
|
in_committee | Brandon J.C. Elefante |
| SB 1527 |
DOH; ADAD; Informational Campaign; Prevention Services; Report; Appropriations 2026 | Senate
|
in_committee | Sharon Y. Moriwaki |
| SB 1595 |
DOH; Medical Cannabis; Out-of-State Patients; Registration; Telehealth; Fees 2026 | Senate
|
in_committee | Brenton Awa |